Taiwan Centers for Disease Control Provisionally Approves Dexamethasone for COVID-19

Aug 5, 2020 | Dexamethasone, News, PPE, Taiwan, Testing

Taiwan Centers for Disease Control Provisionally Approves Dexamethasone for COVID-19

Based on the RECOVERY trial results out of Oxford in the UK, the U.S. NIH sought to place dexamethasone on the clinical guidelines and now Taiwan has provisionally approved the use of dexamethasone, the relatively economical and widely-used steroid.

The Authority

Taiwan’s Centres for Disease Control Deputy Director-General Chuang Jen-hsiang noted they Taiwanese regulatory agency opted to list the steroid as a treatment but that procedures still need completion prior to administration to patients there.

The Island that Beat COVID-19

Taiwan only has 476 reported cases of COVID-19 with seven deaths. The highly organized and mobilized nation has kept cases low thanks to proactive, efficient and effective prevention work from methodical testing to other actions.

What did Taiwan do for its success?

Taiwan learned great lessons from the SARS epidemic of 2003 and hence learned from the past and vowed not to repeat history. From travel bans immediately when the word of Wuhan got out, to careful planning and allocation of personal protective equipment (PPE). A strong and efficient manufacturing base, Taiwan leveraged as well for PPE and associated needs. For a more detailed overview see TrialSite’s Lessons from Taiwan’s Response to COVID-19.”

Source: Reuters

0 Comments

Pin It on Pinterest